124 related articles for article (PubMed ID: 8513598)
1. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases.
Mitsuhashi H; Tsukada Y; Ono K; Yano S; Naruse T
Clin Nephrol; 1993 May; 39(5):231-8. PubMed ID: 8513598
[TBL] [Abstract][Full Text] [Related]
2. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
Tencer J; Torffvit O; Björnsson S; Thysell H; Grubb A; Rippe B
Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
[TBL] [Abstract][Full Text] [Related]
3. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K; Hewitson TD; Kincaid-Smith P
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[TBL] [Abstract][Full Text] [Related]
4. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
[TBL] [Abstract][Full Text] [Related]
5. The urinary excretion of glycosaminoglycans and heparan sulphate in lupus nephritis.
Parildar Z; Uslu R; Tanyalcin T; Doganavsargil E; Kutay F
Clin Rheumatol; 2002 Aug; 21(4):284-8. PubMed ID: 12189454
[TBL] [Abstract][Full Text] [Related]
6. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy.
Gang X; Ueki K; Kon S; Maeda M; Naruse T; Nojima Y
Am J Kidney Dis; 2001 Feb; 37(2):374-9. PubMed ID: 11157380
[TBL] [Abstract][Full Text] [Related]
7. [Expression of glomerular heparan sulfate domains in pediatric patients with minimal change nephrotic syndrome].
Dong LQ; Wang Z; Yu P; Guo YN; Wu J; Feng SP; Li S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):55-8. PubMed ID: 19292045
[TBL] [Abstract][Full Text] [Related]
8. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
[TBL] [Abstract][Full Text] [Related]
9. Urine glycosaminoglycans in congenital and acquired nephrotic syndrome.
Jadresic LP; Filler G; Barratt TM
Kidney Int; 1991 Aug; 40(2):280-4. PubMed ID: 1942776
[TBL] [Abstract][Full Text] [Related]
10. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
[TBL] [Abstract][Full Text] [Related]
11. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
[TBL] [Abstract][Full Text] [Related]
12. Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.
Kobayashi S; Amano H; Terawaki H; Ogura M; Kawaguchi Y; Yokoo T
BMC Nephrol; 2019 Aug; 20(1):306. PubMed ID: 31387546
[TBL] [Abstract][Full Text] [Related]
13. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the modified dimethylmethylene-blue (DMB) method for determining glycosaminoglycans (GAG) in urine].
Moriyama M; Suzuki K; Nakajima C; Kawamura K; Miyazawa K; Tsugawa R
Hinyokika Kiyo; 1994 Jul; 40(7):565-8. PubMed ID: 8085515
[TBL] [Abstract][Full Text] [Related]
15. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
[TBL] [Abstract][Full Text] [Related]
16. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
[TBL] [Abstract][Full Text] [Related]
17. [Study on albumin metabolism in nephrotic syndrome].
Komatsu Y
Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1243-51. PubMed ID: 2082057
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
19. Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity.
De Muro P; Faedda R; Satta AE; Masala A; Cigni A; Falconi D; Sanna GM; Cherchi GM
Scand J Urol Nephrol; 2007; 41(3):230-6. PubMed ID: 17469033
[TBL] [Abstract][Full Text] [Related]
20. Glomerular and urinary heparan sulphate in congenital nephrotic syndrome.
Vermylen C; Levin M; Mossman J; Barratt TM
Pediatr Nephrol; 1989 Apr; 3(2):122-9. PubMed ID: 2534970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
